Plain-English translation of NCT04887116 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing whether virtual reality exposure therapy can help treat trauma symptoms in healthcare workers and COVID-19 patients who experienced difficult events during the pandemic. Exposure therapy is a well-established psychological treatment where patients safely revisit and process their traumatic experiences in a controlled way. Researchers are exploring whether adding virtual reality to this therapy makes it more effective and easier for people to use.
Healthcare workers and COVID-19 patients face high rates of trauma-related stress disorder after their experiences during the pandemic. While this type of therapy has worked well for military veterans and first responders, researchers want to see if this new treatment approach can help these populations specifically.
You likely qualify if…
You likely don't qualify if…
You will attend ten sessions of 90 minutes each, twice per week for five weeks. Sessions can be done either in-person or remotely from home. If you participate remotely, you'll receive a virtual reality headset to use during the study. A clinician will guide you through the therapy, and an independent evaluator will check in on your symptoms at the start, halfway through, at the end, and three months later to see how you're doing.
AI-generated summary from trial data · Sep 17, 2026 · Not medical advice
United States